Lloyd Price

OCTOBER 14, 2024

Overall, HLTH 2024 is expected to be a thought-provoking and informative event that will shape the future of healthcare. Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value.

Leadership 55

Leadership healthcare technology Digital Health Mental health 55

Lloyd Price

DECEMBER 2, 2024

Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Mental health 62

Mental health Digital Health healthcare technology Telehealth 62

Lloyd Price

SEPTEMBER 16, 2024

The conference explored the advancements in precision medicine and its implications for healthcare delivery. Biopharma Innovation and Drug Development: The development of innovative drugs and therapies remains a key focus in the healthcare industry.

Digital Health 62

Digital Health Drug Development healthcare technology Leadership 62

Lloyd Price

AUGUST 3, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Drug development: Assessing treatment efficacy and patient adherence.

Mental health 68

Mental health Pain management Drug Development Leadership 68

Lloyd Price

APRIL 27, 2024

Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare. It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? Visit www.nelsonadvisors.co.uk

healthcare technology 70

healthcare technology Leadership Drug Development Digital Health 70

Lloyd Price

NOVEMBER 8, 2024

The increasing adoption of digital health technologies, the growing importance of AI and ML, and the evolving regulatory landscape will continue to shape the deal landscape. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Digital Health 52

Digital Health healthcare technology Pharmaceuticals Telehealth 52

Lloyd Price

MAY 2, 2024

Digital Biology: Tools like BioNeMo utilise AI to analyse vast amounts of biological data, leading to breakthroughs in drug development and understanding of diseases. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

healthcare technology 70

healthcare technology Drug Development Leadership Digital Health 70

Lloyd Price

MAY 30, 2024

However, these early successes provide a promising outlook for the role and its potential to revolutionise healthcare with the responsible use of AI. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership 70

Leadership healthcare technology Interoperability Drug Development 70

Lloyd Price

APRIL 29, 2024

Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drug development. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Health Data 62

Health Data healthcare technology Digital Health Leadership 62

Lloyd Price

MAY 6, 2024

By incorporating the strengths of weather AI, healthcare AI can become even more powerful in predicting, preventing, and managing health issues, leading to a more personalised and proactive healthcare system. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

healthcare technology 68

healthcare technology Leadership Drug Development Digital Health 68

Lloyd Price

APRIL 22, 2024

Growing Market: The global market for AI in healthcare is projected to reach astronomical figures in the coming years, reflecting the confidence in this technology. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

healthcare technology 59

healthcare technology Leadership Drug Development Digital Health 59

Lloyd Price

FEBRUARY 18, 2024

AI and machine learning: Companies with advanced AI solutions for tasks like drug discovery, clinical trial optimisation, and personalised medicine can be attractive targets. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 62

Pharmaceuticals healthcare technology Digital Health Remote care 62

Lloyd Price

OCTOBER 28, 2024

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Interoperability 70

Interoperability healthcare technology HIPAA Leadership 70

Lloyd Price

FEBRUARY 18, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 59

Pharmaceuticals healthcare technology Leadership Drug Development 59

Healthcare IT Today

NOVEMBER 14, 2022

Technology investments focus on business and healthcare technology, targeting those ideas with quantifiable development risk and a rapid path to market. Animal Health investments focus on disruptive technologies that have a meaningful impact on global animal health and animal agriculture.

Life Science 96

Life Science HIPAA Drug Development healthcare technology 96

Lloyd Price

OCTOBER 9, 2024

Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Mental health 59

Mental health healthcare technology Leadership Digital Health 59

Lloyd Price

DECEMBER 2, 2024

By embracing technological advancements, focusing on personalised medicine, and addressing the challenges of chronic wounds, the industry can improve patient outcomes, reduce costs, and enhance the overall quality of care. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Digital Health 55

Digital Health healthcare technology Telemedicine Leadership 55

Lloyd Price

FEBRUARY 2, 2024

Benefits for healthcare stakeholders: Streamlined patient onboarding: Verifiable credentials from SSI wallets can expedite patient registration and verification, reducing administrative burdens and improving wait times.

Health Data 62

Health Data Interoperability healthcare technology Leadership 62

Lloyd Price

AUGUST 7, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Interoperability 59

Interoperability Leadership EHR Drug Development 59

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development.

BioTech 88

BioTech Life Science Leadership Drug Development 88

Lloyd Price

FEBRUARY 22, 2024

Overall, the pain management market is poised for significant growth, fuelled by technological innovation and a growing demand for effective, non-opioid solutions. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Pain management 55

Pain management Mental health Telehealth healthcare technology 55

Lloyd Price

JULY 15, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Digital Health 59

Digital Health Mobile Health Telehealth Leadership 59

Lloyd Price

SEPTEMBER 6, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership 73

Leadership Drug Development healthcare technology Digital Health 73

Lloyd Price

AUGUST 9, 2023

Exec Summary: The concept of a UK sovereign health fund based on NHS data is still in its early stages of development, but it has the potential to revolutionize the way healthcare is funded and delivered in the UK. The global drug development market is estimated to surpass $100bn by 2027. The value lies in sharing safely."

healthcare technology 52

healthcare technology Healthcare Innovation Drug Development Health Data 52

Healthcare IT News - Telehealth

MAY 6, 2020

iRhythm Technologies. iRhythm is a healthcare technology company that clinically diagnoses cardiac arrhythmias by combining wearable biosensing technology with cloud-based data analytics and machine learning capabilities.

Connected Health 197

Connected Health Telehealth Pharmaceuticals EHR 197

Lloyd Price

SEPTEMBER 29, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership 62

Leadership Drug Development healthcare technology Digital Health 62

DrKumo Remote Patient Monitoring

FEBRUARY 29, 2024

Ethical guidelines and regulatory frameworks must be established to govern the responsible and ethical use of AI in healthcare, safeguarding patient rights and ensuring equitable access to AI-driven healthcare technologies. What are the benefits of AI in drug development?

Mental health 40

Mental health Health Data Drug Development Patient Experience 40

Healthcare IT Today

MAY 5, 2023

Whereas a traditional visit to the doctor can analyze one’s physical health in a fixed time, technology can gather data throughout a patient’s lived experiences, helping healthcare professionals understand patient backgrounds, experiences, and personal preferences on a deeper level. Tanja Dowe, CEO of Debiopharm Innovation Fund S.A.

Drug Development 111

Drug Development Primary Care Remote care Patient Experience 111

Healthcare IT Today

APRIL 25, 2024

Second, leveraging recent breakthroughs in representation learning, the technology elucidates the biological context underlying its predictions. About Zephyr AI Zephyr AI is a high-growth healthcare technology company committed to radically reshaping precision medicine in oncology and cardiometabolic disease.

Drug Development 126

Drug Development healthcare technology Health IT Healthcare IT 126